Literature DB >> 10932150

Biopharmaceutical benchmarks.

G Walsh1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10932150     DOI： 10.1038/78720

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  12 in total

1.  Toxic concentrations of exogenously supplied methylglyoxal in hybridoma cell culture.

Authors:  Benjamin M Roy; Tiffany D Rau; R Robert Balcarcel
Journal:  Cytotechnology       Date:  2005-11-30       Impact factor: 2.058

2.  Induction by hypoxia of heterologous-protein production with the KlPDC1 promoter in yeasts.

Authors:  Andrea Camattari; Michele M Bianchi; Paola Branduardi; Danilo Porro; Luca Brambilla
Journal:  Appl Environ Microbiol       Date:  2006-12-01       Impact factor: 4.792

Review 3.  Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations.

Authors:  R G Thorne; W H Frey
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Elucidation of PEGylation site with a combined approach of in-source fragmentation and CID MS/MS.

Authors:  Xiaojun Lu; P Clayton Gough; Michael R DeFelippis; Lihua Huang
Journal:  J Am Soc Mass Spectrom       Date:  2010-01-25       Impact factor: 3.109

5.  Isolation of anti-angiogenesis antibodies from a large combinatorial repertoire by colony filter screening.

Authors:  L Giovannoni; F Viti; L Zardi; D Neri
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

6.  Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris.

Authors:  Byung-Kwon Choi; Piotr Bobrowicz; Robert C Davidson; Stephen R Hamilton; David H Kung; Huijuan Li; Robert G Miele; Juergen H Nett; Stefan Wildt; Tillman U Gerngross
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

Review 7.  Production of biopharmaceutical proteins by yeast: advances through metabolic engineering.

Authors:  Jens Nielsen
Journal:  Bioengineered       Date:  2012-11-12       Impact factor: 3.269

8.  Chitosan-decorated selenium nanoparticles as protein carriers to improve the in vivo half-life of the peptide therapeutic BAY 55-9837 for type 2 diabetes mellitus.

Authors:  Lei Rao; Yi Ma; Manjiao Zhuang; Tianjie Luo; Yayu Wang; An Hong
Journal:  Int J Nanomedicine       Date:  2014-10-17

Review 9.  Protein fusion tags for efficient expression and purification of recombinant proteins in the periplasmic space of E. coli.

Authors:  Ajamaluddin Malik
Journal:  3 Biotech       Date:  2016-02-04       Impact factor: 2.406

10.  The relationship between mTOR signalling pathway and recombinant antibody productivity in CHO cell lines.

Authors:  Raihana Edros; Susan McDonnell; Mohamed Al-Rubeai
Journal:  BMC Biotechnol       Date:  2014-02-17       Impact factor: 2.563
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.